Chilblain-Like Lesions During COVID-19 Tied to Type I Interferonopathy
TUESDAY, Dec. 1, 2020 -- Patients presenting with chilblain-like lesions during the COVID-19 pandemic have histologic and biologic patterns of type I interferonopathy, according to a study published online Nov. 25 in JAMA Dermatology.
Thomas Hubiche, M.D., from Université Côte d'Azur in Nice, France, and colleagues assessed 40 consecutive patients presenting with chilblain-like lesions during the COVID-19 pandemic. Patients underwent skin biopsies, vascular investigations, biologic analyses, interferon-alpha stimulation and detection, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction and serologic analysis.
The researchers found that most patients were young, with a median age of 22 years, and 19 patients were male. Chilblain-like lesions were mostly on the toes. Eleven patients had bullous and necrotic evolution, while 19 had acrocyanosis or cold toes. Just over one-fourth of patients (27.5 percent) had criteria compatible with COVID-19 cases within six weeks of the eruption, although all rapid testing results were negative. SARS-CoV-2 serology results were positive in 12 patients (30 percent). Six in 10 patients had elevated D-dimer concentration levels. All patients tested negative for cryoglobulinemia and parvovirus B19. Lymphocytic inflammation and vascular damage with thickening of venule walls and pericyte hyperplasia were the major histologic findings.
"Taken together, our results suggest that chilblain-like lesions observed during the COVID-19 pandemic represent manifestations of a viral-induced type I interferonopathy," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: December 2020
Further Support and Information on COVID-19
Read this next
Admission for SARS-CoV-2 Down With Prior Metabolic Surgery
TUESDAY, Dec. 1, 2020 -- Prior metabolic surgery and subsequent weight loss are associated with reduced rates of hospital admission for patients with obesity who are infected with...
Diabetic Retinopathy May Up Risk for COVID-19 Intubation
TUESDAY, Dec. 1, 2020 -- For patients with diabetes hospitalized with COVID-19, the risk for intubation is increased more than fivefold for those with diabetic retinopathy,...
Risk for SARS-CoV-2 Infection Lower for O, Rh− Blood Groups
TUESDAY, Dec. 1, 2020 -- Type O and rhesus-negative (Rh−) blood groups seem to be associated with a lower risk for severe acute respiratory syndrome coronavirus 2...